跳至主要内容
临床试验/NCT07786350
NCT07786350已完成不适用

The Effect of Thiamine, Ascorbic Acid, and Their Combination on Matrix Metalloproteinase-9 (MMP-9), Tissue Inhibitor of Metalloproteinase-1 (TIMP-1), and Inflammatory Balance (IL-6/IL-10) in Adult Sepsis Patients: A Two-Center Randomized Controlled Trial

Universitas Sumatera Utara0 个研究点目标入组 40 人开始时间: 2020年4月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
40
主要终点
Change in serum MMP-9 concentration

研究概览

简要总结

This two-center, open-label randomized controlled trial evaluated the effect of adjunctive thiamine, ascorbic acid, and their combination compared with 0.9% saline on the extracellular matrix-remodeling axis (matrix metalloproteinase-9 [MMP-9] and tissue inhibitor of metalloproteinase-1 [TIMP-1]) and the inflammatory-balance axis (interleukin-6 [IL-6] and interleukin-10 [IL-10]) in adult patients with sepsis. Serum biomarkers were measured by ELISA at baseline and after 72 hours and related to organ dysfunction (SOFA score), acute kidney injury, and in-hospital mortality.

详细描述

Forty adults admitted to the intensive care unit with sepsis (SOFA score >= 2 and arterial lactate >= 2 mmol/L) were randomized using a computer-generated sequence to four parallel arms: control (0.9% saline), thiamine 200 mg, ascorbic acid 50 mg/kg body weight, or the thiamine plus ascorbic acid combination. Study drugs were infused over 60 minutes every 12 hours for three days, in addition to the standard hour-1 sepsis bundle. MMP-9, TIMP-1, IL-6, and IL-10 were quantified by ELISA at baseline and 72 hours. Outcomes included the MMP-9/TIMP-1 ratio, the IL-6/IL-10 balance, SOFA score, acute kidney injury, and in-hospital mortality.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults aged 18 years or older
  • Admitted to the intensive care unit with sepsis (Sepsis-3)
  • SOFA score >= 2
  • Arterial lactate >= 2 mmol/L

排除标准

  • * Known allergic reaction to thiamine or ascorbic acid

结局指标

主要结局

Change in serum MMP-9 concentration

时间窗: Baseline and 72 hours

Serum matrix metalloproteinase-9 (pg/mL) measured by ELISA

Change in serum TIMP-1 and MMP-9/TIMP-1 ratio

时间窗: Baseline and 72 hours

Serum TIMP-1 (pg/mL) and the MMP-9/TIMP-1 ratio by ELISA.

次要结局

  • Change in serum IL-6 and IL-10 concentrations(Baseline and 72 hours)
  • SOFA score(Baseline and 72 hours)
  • Acute kidney injury(Through ICU discharge, up to 28 days)
  • In-hospital mortality(Through hospital discharge, up to 28 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Bastian Lubis

Principal Investigator

Universitas Sumatera Utara

相似试验